CELLINK, a global leader in developing and delivering life-science solutions, has joined forces with Lonza, the Swiss Chemicals and Biotechnology Company, to offer a comprehensive
CELLINK AB, a Swedish Bio-Tech Startup, announced that it is entered into an agreement to acquire a german life-science company ‘cytena’, for 30 Million euros.
Swedish Bio-Tech Startup CELLINK, recently introduced 7 new bioinks and 3 New Kits to allow scientists and researchers to construct skin and other similar structures.